{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:32:51Z","timestamp":1795123971561,"version":"4.10.3"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:p>Pain is common and poorly managed in patients with advanced CKD, likely due to both under and over prescription of appropriate analgesics. Poorly managed pain contributes to patients\u2019 poor quality of life and excessive health care use. There is tremendous variability within and between countries in prescribing patterns of analgesics, suggesting that factors other than patient characteristics account for these differences. This article discusses the pharmacologic management of acute and chronic pain in patients with advanced CKD, and the role analgesics, including opioids, play in the overall approach to pain management.<\/jats:p>","DOI":"10.2215\/cjn.05180418","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T15:25:14Z","timestamp":1551713114000},"page":"917-931","source":"Crossref","is-referenced-by-count":112,"title":["Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure"],"prefix":"10.2215","volume":"14","author":[{"given":"Sara N.","family":"Davison","sequence":"first","affiliation":[{"name":"Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/sdi.12196","article-title":"Pain in chronic kidney disease: A scoping review","volume":"27","author":"Davison","year":"2014","journal-title":"Semin Dial"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1093\/ndt\/gfl380","article-title":"Longitudinal validation of a modified Edmonton symptom assessment system (ESAS) in haemodialysis patients","volume":"21","author":"Davison","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jpainsymman.2005.05.013","article-title":"The impact of chronic pain on depression, sleep, and the desire to withdraw from dialysis in hemodialysis patients","volume":"30","author":"Davison","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2215\/CJN.00820207","article-title":"Pain, sleep disturbance, and quality of life in patients with chronic kidney disease","volume":"2","author":"Cohen","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jpainsymman.2009.08.008","article-title":"Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients","volume":"39","author":"Davison","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2215\/CJN.00220114","article-title":"Associations of depressive symptoms and pain with dialysis adherence, health resource utilization, and mortality in patients receiving chronic hemodialysis","volume":"9","author":"Weisbord","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/S0140-6736(11)60402-9","article-title":"Treatment of chronic non-cancer pain","volume":"377","author":"Turk","year":"2011","journal-title":"Lancet"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/20786204.2006.10873406","article-title":"Pain management in palliative care","volume":"48","author":"Barnard","year":"2006","journal-title":"S Afr Fam Pract"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1681\/ASN.2006050477","article-title":"Efficacy of the world health organization analgesic ladder to treat pain in end-stage renal disease","volume":"17","author":"Barakzoy","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.emc.2015.11.002","article-title":"The opioid epidemic in the United States","volume":"34","author":"Wilkerson","year":"2016","journal-title":"Emerg Med Clin North Am"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jgs.12148","article-title":"Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults","volume":"61","author":"Rolita","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2215\/CJN.09910917","article-title":"Opioid analgesics and adverse outcomes among hemodialysis patients","volume":"13","author":"Ishida","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/pm\/pnw238","article-title":"Opioid use in chronic pain patients with chronic kidney disease: A systematic review","volume":"18","author":"Nagar","year":"2017","journal-title":"Pain Med"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1681\/ASN.2017010098","article-title":"Opioid prescription, morbidity, and mortality in United States dialysis patients","volume":"28","author":"Kimmel","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/ndt\/gfn745","article-title":"Acetaminophen, aspirin and progression of advanced chronic kidney disease","volume":"24","author":"Evans","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"143","DOI":"10.14336\/AD.2017.0306","article-title":"A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly","volume":"9","author":"Wongrakpanich","year":"2018","journal-title":"Aging Dis"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/bmj.316.7128.333","article-title":"Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs","volume":"316","author":"Moore","year":"1998","journal-title":"BMJ"},{"issue":"6","key":"B22-20230813","first-page":"CD007402","article-title":"Topical NSAIDs for acute pain in adults","volume":"16","author":"Massey","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"B26-20230813","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00520-016-3447-0","article-title":"The use of opioids in cancer patients with renal impairment-a systematic review","volume":"25","author":"Sande","year":"2017","journal-title":"Support Care Cancer"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/978-0-387-73693-8_85","article-title":"Naloxone reversal of opioid-induced respiratory depression with special emphasis on the partial agonist\/antagonist buprenorphine","volume":"605","author":"Sarton","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3959(96)03140-5","article-title":"A systematic review of antidepressants in neuropathic pain","volume":"68","author":"McQuay","year":"1996","journal-title":"Pain"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s40261-013-0080-2","article-title":"Cross-over, open-label trial of the effects of gabapentin versus pregabalin on painful peripheral neuropathy and health-related quality of life in haemodialysis patients","volume":"33","author":"Atalay","year":"2013","journal-title":"Clin Drug Investig"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1053\/j.ajkd.2017.05.010","article-title":"Treatment of gabapentin toxicity with peritoneal dialysis: Assessment of gabapentin clearance","volume":"70","author":"Ibrahim","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B32-20230813","article-title":"Detecting aberrant opioid behavior in the emergency department: A prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP\u00ae-R), Current Opioid Misuse Measure (COMM)\u2122, and provider gestalt [published online ahead of print March 3, 2018]","author":"Varney","journal-title":"Intern Emerg Med"},{"key":"B33-20230813","first-page":"45","article-title":"\u201cWeak\u201d opioid analgesics. Codeine, dihydrocodeine and tramadol: No less risky than morphine","volume":"25","year":"2016","journal-title":"Prescrire Int"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jcpt.12484","article-title":"Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: A meta-analysis","volume":"42","author":"Gunter","year":"2017","journal-title":"J Clin Pharm Ther"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/clpt.1980.94","article-title":"Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient","volume":"27","author":"Gibson","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"B37-20230813","first-page":"275","article-title":"Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an \u2018atypical\u2019 opioid analgesic","volume":"260","author":"Raffa","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0025-6196(11)60750-7","article-title":"Opioid metabolism","volume":"84","author":"Smith","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"B39-20230813","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1191\/0269216303pm658oa","article-title":"Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain","volume":"17","author":"Quigley","year":"2003","journal-title":"Palliat Med"},{"key":"B40-20230813","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0952-8180(95)00092-5","article-title":"The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation","volume":"8","author":"Kirvela","year":"1996","journal-title":"J Clin Anesth"},{"key":"B41-20230813","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.smj.0000242876.45747.0a","article-title":"Oxycodone accumulation in a hemodialysis patient","volume":"100","author":"Foral","year":"2007","journal-title":"South Med J"},{"key":"B42-20230813","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5055\/jom.2015.0265","article-title":"The pharmacokinetics of oxycodone and its metabolites following single oral doses of Remoxy\u00ae, an abuse-deterrent formulation of extended-release oxycodone, in patients with hepatic or renal impairment","volume":"11","author":"Malhotra","year":"2015","journal-title":"J Opioid Manag"},{"key":"B43-20230813","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1191\/0269216305pm1004cr","article-title":"Measurements of plasma oxycodone, noroxycodone and oxymorphone levels in a patient with bilateral nephrectomy who is undergoing haemodialysis","volume":"19","author":"Lee","year":"2005","journal-title":"Palliat Med"},{"key":"B44-20230813","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/papr.12483","article-title":"Dialyzability of oxycodone and its metabolites in chronic noncancer pain patients with end-stage renal disease","volume":"17","author":"Samolsky Dekel","year":"2017","journal-title":"Pain Pract"},{"key":"B45-20230813","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/cpdd.238","article-title":"Effects of renal impairment and hepatic impairment on the pharmacokinetics of hydrocodone after administration of a hydrocodone extended-release tablet formulated with abuse-deterrence technology","volume":"5","author":"Darwish","year":"2016","journal-title":"Clin Pharmacol Drug Dev"},{"key":"B47-20230813","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0376-8716(80)90180-5","article-title":"Methadone use in patients with chronic renal disease","volume":"5","author":"Kreek","year":"1980","journal-title":"Drug Alcohol Depend"},{"key":"B48-20230813","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/bja\/64.3.276","article-title":"Buprenorphine disposition in patients with renal impairment: Single and continuous dosing, with special reference to metabolites","volume":"64","author":"Hand","year":"1990","journal-title":"Br J Anaesth"},{"issue":"Suppl 2","key":"B49-20230813","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0376-8716(03)00058-9","article-title":"Pharmacokinetics of the combination tablet of buprenorphine and naloxone","volume":"70","author":"Chiang","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"B50-20230813","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejpain.2005.12.001","article-title":"Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine","volume":"10","author":"Filitz","year":"2006","journal-title":"Eur J Pain"},{"key":"B51-20230813","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1073\/pnas.70.1.10","article-title":"Methadone plasma level: Sustained by a reservoir of drug in tissue","volume":"70","author":"Dole","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"B52-20230813","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.pain.2013.08.015","article-title":"Intradialytic clearance of opioids: Methadone versus hydromorphone","volume":"154","author":"Perlman","year":"2013","journal-title":"Pain"},{"key":"B53-20230813","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1213\/00000539-199802000-00049","article-title":"Nondialyzability of fentanyl with high-efficiency and high-flux membranes","volume":"86","author":"Joh","year":"1998","journal-title":"Anesth Analg"},{"key":"B54-20230813","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.clinthera.2015.04.009","article-title":"Effects of hemodialysis on methadone pharmacokinetics and QTc","volume":"37","author":"Opdal","year":"2015","journal-title":"Clin Ther"},{"key":"B55-20230813","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ndt\/14.1.254","article-title":"Methadone is poorly removed by haemodialysis","volume":"14","author":"Furlan","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"B56-20230813","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0091270003251119","article-title":"Pharmacokinetics of Pregabalin in Subjects with Various Degrees of Renal Function","volume":"43","author":"Randinitis","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"B57-20230813","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"B58-20230813","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0091270003251119","article-title":"Pharmacokinetics of pregabalin in subjects with various degrees of renal function","volume":"43","author":"Randinitis","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"B59-20230813","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/15563658008989993","article-title":"Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis","volume":"17","author":"Lee","year":"1980","journal-title":"Clin Toxicol"},{"key":"B60-20230813","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2125.1999.00973.x","article-title":"Pharmacokinetic and pharmacodynamic characterization of OROS and immediate-release amitriptyline","volume":"48","author":"Gupta","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"B61-20230813","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00630290","article-title":"Metabolism of amitriptyline in patients with chronic renal failure","volume":"26","author":"Sandoz","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"B62-20230813","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pain.2008.12.003","article-title":"Ketamine for chronic non-cancer pain","volume":"141","author":"Bell","year":"2009","journal-title":"Pain"},{"key":"B63-20230813","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol Rev"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201906000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:38:21Z","timestamp":1786369101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201906000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.05180418","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]}}}